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ABSTRACT. Mucocutaneous manifestations are common among patients on hemodialysis (HD).
This study was undertaken to determine the prevalence of mucocutaneous manifestations in patients
with end-stage renal disease (ESRD) who are on HD. In this cross-sectional, descriptive and analytic
study conducted in 2009, 100 patients on HD at the Five Azar Hospital in Gorgan city were randomly
selected. All the patients underwent detailed examination by a dermatologist to look for lesions in the
skin, hair, nail and mucous membranes; if felt necessary, biopsy was obtained from the lesions. The
findings were statistically analyzed using SPSS-13 software. For evaluation of normality of distri-
bution, Kolmogorov-Smirnov was used, for quantitative variables Mann–Whitney and T-test (abnor-
mal distribution) were used and for qualitative variables, Chi-2 and Fisher were used. In this study, P-
value less than 0.05 was considered significant. Fifty-one males and 49 females were enrolled. The
mean age was 49 ± 12 years. Diabetes was the most common cause of ESRD. In 95% of the patients,
at least one mucocutaneous manifestation was present. Xerosis (78.3%) was the most common lesion,
followed by pruritus (39.1%), lentigo (34.8%), skin discoloration (32.6%), leukonychia (32%) and
thinning of the nail bed (24%). Xerosis, scaling, lentigo, folliculitis, idiopathic guttate hypo-pigmen-
tation, leukonychia and half and half nail were associated with age. A significant relationship was seen
between duration on dialysis and skin discoloration and leukonychia. Clubbing had a significant
association with calcium–phosphorus product (Ca × P). There was a significant association between
serum ferritin level and pruritus and tinea versicolor lesions. Our study shows that mucocutaneous
manifestations are common among patients with ESRD. Identification of these manifestations and
their association with causative factors are useful for preventing the lesions.
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Introduction
The prevalence of mucocutaneous manifest-
tations is high among dialysis patients. This
occurs because of numerous factors such as
uremia, metabolic disorders, dialysis and side-
effects of immunosuppressive drugs. Patients
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on hemodialysis (HD) are known to develop
cutaneous manifestations ranging from infec-
tions to malignancies.1 Broadly, in all patients
with advanced renal insufficiency, at least one
cutaneous manifestation has been observed,
and the most common lesion is skin disco-
loration.2 In addition, new cutaneous lesions
may develop with increasing age. Sometimes,
cutaneous changes maybe the first important
sign in patients with chronic renal failure.3
Prolonged dialysis is associated with muco-
cutaneous changes.4,5 Among them, pruritus
has been reported as being the most common
in some investigations. Although its etio-
pathogenesis is unknown, factors such as se-
condary hyper-parathyroidism, two-capacity ion
disturbance, allergy, iron deficiency anemia,
neuropathy and mast cell proliferation have
been suggested as causative factors.6 In some
other studies, skin discoloration has been men-
tioned as the most common cutaneous com-
plication.7 Cutaneous lesions in patients with
end-stage renal disease (ESRD) are cate-
gorized into specific and non-specific lesions.8
Reports from different parts of Iran have
described various cutaneous manifestations in
patients on HD, which differ based on race,
nutritional condition, geographic location, socio-
economic status of the patients and accuracy
of patients’ examination.9
Because cutaneous manifestations may have
a cosmetically destructive effect, in addition to
complications such as pruritus that disturbs the
patient’s comfort, we designed this study to
determine the prevalence of mucocutaneous
manifestations in patients on HD at the Five
Azar Hospital in Gorgan and demonstrate its
relationship with factors such as gender, age,
duration on dialysis, serum ferritin level and
calcium–phosphorous product. Detecting this
relationship might help in finding a way for
reducing these lesions.
Materials and Methods
In this cross-sectional, descriptive, analytic
study, 100 patients on HD at the Five Azar
Hospital were selected by a regular random
method. Written consent was obtained from all
the study patients. All the study patients were
examined in detail by a dermatologist in a
location with adequate light and routine ins-
truments for skin examination, such as manual
light, magnifying glass, etc. Biopsy from the
cutaneous lesions was taken, when felt
necessary. A pathologist would then examine the
biopsy samples and the findings were entered
in previously prepared forms. Demographic
information such as age and gender, cause of
renal failure and duration on dialysis were
extracted from the patients’ files. Information
about the patients’ laboratory tests were ob-
tained from the mean of three recent tests.
Calcium–phosphorus product more than 55
and serum ferritin level greater than 800
ng/mL were considered high values.
Statistical Analysis
Data were analyzed using SPSS software
(Statistics Package for Social Sciences version
13 SPSS Inc; Chicago, IL, USA). Kolmogorov-
Smirnov was used for testing normality. We
used the t-test to evaluate the association bet-
ween age and muco-cutaneous manifestations
and Mann–Whitney test to assess the relation-
ship between duration on dialysis and muco-
cutaneous manifestations for quantitative data,
and chi-2 and Fisher tests for qualitative data.
In this study, P-value less than 0.05 was consi-
dered statistically significant.
Results
Of the 100 patients enrolled in the study, 51
(51%) were male and 49 (49%) were female.
Mean age of the patients was 49 ± 12.3 years
and mean duration on dialysis was 40 ± 13
months. Diabetes was the most common cause
of renal failure in these patients (n = 45),
followed by hypertension (n = 28), glomerulo-
nephritis (n = 13), polycystic kidney (n = 4)
reflux nephropathy (n = 4) and unknown cause
in six cases. Xerosis was the most common skin
manifestation in these patients, and was seen
in 78.3% of the patients. This was followed in
frequency by pruritus (39.1%), lentigo (34.8%),
skin discoloration (32.6%), leukonychia (32%)
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and thinning of the nail bed (24%). The pre-
valence and binomial exact 95% confidence
interval (CI) of the mucous membrane and
cutaneous manifestations in the study patients
have been shown in Table 1.
Results of the chi-2 test showed that asso-
ciation between gender and lentigo was statis-
tically significant (P = 0.042); 21 females ver-
sus 11 males had lentigo. Association between
age and cutaneous manifestations has been
shown in Table 2. The association between age
and xerosis (P <0.01), scaling (P = 0.04), len-
tigo (P <0.01), folliculitis (P <0.01), idiopathic
guttate hypo-pigmentation (P <0.01), leuko-
nychia (P = 0.01) and half and half nail (P
<0.01) was statistically significant.
Increasing duration on dialysis showed a sig-
nificant association with cutaneous discolo-
ration (P = 0.031) and leukonychia (P =
0.041). The Ca × P product was significantly
associated only with digital clubbing (P =
0.027), while the serum ferritin level had a sig-
nificant association with pruritus (P = 0.048)
and fungal lesion (tinea versicolor) (P = 0.047).
Discussion
Patients with ESRD who are on HD present
with various mucocutaneous manifestations. In
the current study, 95% of the patients had at
least one mucocutaneous lesion. Among these
manifestations, skin xerosis is one of the most
common findings, and was seen in 78.3% of
the patients in our study. The prevalence of
xerosis has been reported from to be 65% to
79% in various studies.3,7,8 In a study per-
formed by Haji Heidari et al,9 the prevalence
of xerosis was 23%. This difference may be
related to the prevailing climatic conditions;
other factors might also be present. In our
study, there was a significant association bet-
ween skin xerosis and increasing age in the
patients. Another common cutaneous manifes-
tation in our study was pruritus, with a pre-
valence rate of 39.1%. In the different studies
published, the prevalence of pruritus has varied
Table 1. Prevalence and binomial exact 95% confidence interval (CI) of mucous membrane and
cutaneous manifestations in patients with advanced and end-stage renal failure.
Manifestation Number Prevalence % 95% CI of prevalence
Discoloration 30 32.6 23.2–43.17
Pruritus 36 39.1 29.11–49.86
Xerosis 72 78.3 68.44–86.18
Scaling 19 20.7 12.91–30.35
Lentigo 32 34.8 25.14–45.42
Folliculitis 4 4.3 1.20–10.75
Ecchymosis 6 6.5 2.43–13.65
Tinea versicolor 4 4.3 1.20–10.75
Idiopathic guttate hypomelanosis 20 21.7 13.81–31.55
Scrotal tongue 4 4 1.10–9.92
Glossitis 2 2 0.26–7.63
Oral candida 2 2 0.26–7.63
Pigmentation of mucous membrane 2 2 0.26–7.63
Leukonychia 32 32 23.02–42.07
Pitting 8 8 3.51–15.15
Thinning of nail plate 24 24 16 02–33.57
Half and half nail 8 8 3.51–15.15
Koilonychia 5 5 1.64–11.28
Clubbing 3 3 0.62–8.51
Subungual hyperkeratosis 7 7 2.8–13.90
Tinea unguis 2 2 0.26–7.63
Hirsutism 3 3 0.62–8.51
Eyebrow hair loss 7 7 2.8–13.90
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between 19% and 90%.2,3,7,8,10,11 The severity
of pruritus was variable; the majority com-
plained of severe and frequent pruritus that
resulted in disturbance of sleep and daily acti-
vity. In one study, one-third of the patients
before initiating HD and two-third of the pa-
tients after initiating HD complained of pru-
ritus.10 In another study, pruritus began after
starting HD in about 50% of the patients.9 In
our study, because of incomplete patient his-
tory, we could not find any association bet-
ween pruritus and the time of commencement
of HD. In addition, no significant association
was found with dialysis duration; however,
there was a significant association between
serum ferritin level and occurrence of pruritus.
Another common cutaneous manifestation was
lentigo, which was detected in 34.8% of the
patients; this finding has not been reported in
the study of Roudsari et al,12 while in the study
of Haji Heidari et al, the reported prevalence
was 1%.9 In our study, lentigo showed a sig-
nificant association with increasing age. Skin
discoloration was the next common finding,
seen in 32.6% of our study patients. Udayakuma
et al have reported a prevalence of hyper-
pigmentation of 43%,3 while in the report of
Haji Heidari et al, the prevalence of skin
discoloration was 66.33%.9 In the study of
Pico et al, alteration in skin color was the most
common finding.2 This discoloration has been
reported as paling, becoming yellow and hyper-
pigmentation. These studies have shown that
hyper-pigmentation increases with increasing
duration on dialysis;7 however, Pico et al
showed that hypo-pigmentation decreases with
increasing dialysis duration.2 In our study,
there was a direct relationship between dialysis
Table 2. Association between age and mucocutaneous manifestations in the patients with advanced end-
stage renal failure.
Age (mean ± SD)Manifestation Present Not present P-value
Discoloration 48.9 ± 14.7 52.5 ± 18.7 0.350
Pruritis 50.7 ± 17.8 51.7 ± 17.4 0.792
Xerosis 54.3 ± 16.3 40.7 ± 17.90 <0.01
Scaling 58.6 ± 14.9 49.4 ± 17.7 0.040
Acne 37 ± 11.37 52 ± 17.5 0.094
Vitiligo 68 ± 9.8 50.8 ± 17.5 0.094
Bulla 52 ± 0 51.3 ± 17.6 -
Lentigo 61.5 ± 14.5 45.9 ± 16.6 <0.01
Folliculitis 73.7 ± 10.2 50.3 ± 17.1 <0.01
Ecchymosis 63.7 ± 15.8 50.5 ± 17.4 0.074
Tinea versicolor 36.2 ± 12 52 ± 17.4 0.078
Idiopathic guttate hypomelanosis 62.5 ± 14 48.2 ± 17.2 <0.01
Scrotal tongue 49.5 ± 11.7 51.8 ± 17.9 0.797
Oral candida 60.5 ± 16.3 51.6 ± 17.7 0.481
Pigmentation of mucus membrane 60.5 ± 6.4 51.6 ± 17.8 0.0481
Leukonychia 58.1 ± 14.9 48.8 ± 18.1 0.013
Pitting 58.2 ± 12 51.2 ± 18 0.279
Thinning of nail bed 52.2 ± 17.4 51.6 ± 17.8 0.893
Half and half nail 73.9 ± 11.3 49.8 ± 16.8 <0.01
Koilonychia 60.8 ± 14.2 51.3 ± 17.7 0.241
Clubbing 40.7 ± 5.1 52.1 ± 17.8 0.272
Subungal hyperkeratosis 61.3 ± 11.6 51.2 ± 17.8 0.138
Tinea unguis 69 ± 8.5 51.4 ± 17.6 0.163
Hirsuitism 61.3 ± 12.0 51.4 ± 17.7 0.341
Eyebrow hair loss 59.8 ± 13.2 51.1 ± 17.8 0.208
Onycolysis 58.5 ± 9.2 53.0 ± 17.8 0.676
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duration and hyper-pigmentation. Although
hyper-pigmentation has been reported as the
most common cutaneous finding in patients
with chronic renal failure, some cases of hypo-
pigmentation have been reported in these
patients.13 In our recent study, three cases had
vitiligo. Idiopathic guttate hypo-pigmentation
was detected in 20 cases among our study
patients that had significant association with
increasing age. We found post-inflammatory
hypo-pigmentation in two patients. Another
common manifestation was leukonychia, which
was found in 32% of the study patients. In
other studies, its prevalence was 23–31%.2,7,8
Haji Heidari et al reported a prevalence of
leukonychia of 16.8% in their study. In this
study, the association between leukonychia
and age was significant. In our study patients,
nail changes were present in 57 patients (57%),
and the most common finding was thinning of
the nail bed, seen in 24% of the patients. In the
study of Hajheidari et al, the prevalence was
45%; this was the most common finding they
encountered.9 Mucosal disorders were seen in
10% of our study patients, with the most com-
mon manifestation being the scrotal tongue
(4%). Hajheidari et al have reported a preva-
lence of 24%, with the most common finding
being furred tongue (8%),9 while Yaghubi et al
reported a prevalence of mucosal disorders of
29%, with the most common finding being
gingivitis.8 Fungal lesions have been reported
in 0–70% of patients with ESRD in various
studies.2,7,9 In our study, cutaneous fungal le-
sions (tinea versicolor) were detected in 4.3%
of the patients, and its association with serum
ferritin level was significant. Nail fungal le-
sions have been reported in 2% of the patients.
Hajheidari et al did not find any patients with
fungal infection in their study,9 while Naderi et
al reported fungal infection in 1.9%7 and Pico
et al in 70% of their patients.2
In conclusion, mucocutaneous manifestations
are common in patients with ESRD on HD.
The reported prevalence rates vary in different
studies. These differences may be examiner-
related or may be due to environmental factors
and laboratory differences at the time of exa-
mination.
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